Castrate-resistant Prostate Cancer (CRPC)
4 clinical trials · Condition
◉ Watch Castrate-resistant Prostate Cancer (CRPC)
| Record | Firm | Date |
|---|---|---|
| An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (NCT03690141) | Effector Therapeutics | 2018-11-27 |
| Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy (NCT01450683) | Stanford University | 2010-09-01 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer (NCT01020305) | Sandy Srinivas | 2009-10-01 |
| MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer (NCT00868595) | Bellicum Pharmaceuticals | 2009-04-01 |
Track Castrate-resistant Prostate Cancer (CRPC) automatically
Every clearance here is in the API, with alerts when new ones post.